Future Perspectives: Metabolic Imaging, Theranostics, and Radiomics

Medicine and Dentistry

• Radiomics 100%
• Soft Tissue Sarcoma 66%
• Physiological Process 66%
• Metastatic Carcinoma 33%
• Biological Marker 33%
• Malignant Neoplasm 33%
• Disease Exacerbation 33%
• Radioactive Tracer 33%
• Therapeutic Agent 33%
• Tumor Marker 33%
• Cell Receptor 33%
• Cancer Stages 33%
• Prognostication 33%
• Molecular Imaging 33%
• Soft Tissue Tumor 33%
• Cancer 33%
• Clinical Decision Making 33%
• Diseases 33%
• Treatment Outcome 33%